Ignite Creation Date:
2025-12-24 @ 4:49 PM
Ignite Modification Date:
2025-12-26 @ 5:15 PM
Study NCT ID:
NCT05172050
Status:
COMPLETED
Last Update Posted:
2023-12-26
First Post:
2021-12-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Multicenter Double Blind, Parallel-group Phase 2/3 Trial, to Study Raloxifene in Adult COVID-19 Patients.
Sponsor:
Dompé Farmaceutici S.p.A
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-01-22
Start Date Type:
ACTUAL
Primary Completion Date:
2021-06-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-06-12
Completion Date Type:
ACTUAL
First Submit Date:
2021-12-23
First Submit QC Date:
None
Study First Post Date:
2021-12-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-06-06
Results First Submit QC Date:
None
Results First Post Date:
2023-12-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-21
Last Update Post Date:
2023-12-26
Last Update Post Date Type:
ACTUAL